Complement regulation in innate immunity and the acute-phase response: Inhibition of mannan-binding lectin-initiated complement cytolysis by C- reactive protein (CRP)

41Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

Mannan-binding lectin (MBL) is an acute-phase protein which activates complement at the level of C4 and C2. We recently reported that the alternative pathway also is required for haemolysis via this 'lectin pathway' in human serum. CRP is another acute-phase reactant which activates the classical pathway, but CRP also inhibits the alternative pathway on surfaces to which it binds. Since serum levels of both proteins generally increase with inflammation and tissue necrosis, it was of interest to determine the effect of CRP on cytolysis via the lectin pathway. We report here that although CRP increases binding of C4 to MBL-sensitized erythrocytes, which in turn enhances lectin pathway haemolysis, it inhibits MBL-initiated cytolysis by its ability to inhibit the alternative pathway. This inhibition is characterized by increased binding of complement control protein H and decreased binding of C3 and C5 to the indicator cells, which in turn is attributable to the presence of CRP. Immunodepletion of H leads to greatly enhanced cytolysis via the lectin pathway, and this cytolysis is no longer inhibited by CRP. These results indicate that CRP regulates MBL-initiated cytolysis on surfaces to which both proteins bind by modulating alternative pathway recruitment through H, pointing to CRP as a complement regulatory protein, and suggesting a co-ordinated role for these proteins in complement activation in innate immunity and the acute-phase response.

Cite

CITATION STYLE

APA

Suankratay, C., Mold, C., Zhang, Y., Potempa, L. A., Lint, T. F., & Gewurz, H. (1998). Complement regulation in innate immunity and the acute-phase response: Inhibition of mannan-binding lectin-initiated complement cytolysis by C- reactive protein (CRP). Clinical and Experimental Immunology, 113(3), 353–359. https://doi.org/10.1046/j.1365-2249.1998.00663.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free